New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802 · see citing works

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30470-2 · Cited by 8,167 · see citing works

Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)

Constantinescu, C. S., Farooqi, N., O'Brien, K., & Gran, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01302.x · Cited by 1,523 · see citing works

Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

International Multiple Sclerosis Genetics Consortium, Patsopoulos, N. A., Baranzini, S. E., Santaniello, A., Shoostari, P., Cotsapas, C., Wong, G., Beecham, A. H., James, T., Replogle, J., et al. (2019) · Science · doi:10.1126/science.aav7188 · Cited by 1,471 · see citing works

How common are the "common" neurologic disorders?

Hirtz, D., Thurman, D. J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A. R., & Zalutsky, R. (2007) · Neurology · doi:10.1212/01.wnl.0000252807.38124.a3 · Cited by 1,365 · see citing works

Inflammatory cortical demyelination in early multiple sclerosis.

Lucchinetti, C. F., Popescu, B. F. G., Bunyan, R. F., Moll, N. M., Roemer, S. F., Lassmann, H., Brück, W., Parisi, J. E., Scheithauer, B. W., Giannini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100648 · Cited by 1,103 · see citing works

Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Wallin, M. T., Culpepper, W. J., Nichols, E., Bhutta, Z. A., Gebrehiwot, T. T., Hay, S. I., Khalil, I. A., Krohn, K. J., Liang, X., Naghavi, M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30443-5 · Cited by 1,108 · see citing works

The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK

MacDonald, B. K. (2000) · Brain · doi:10.1093/brain/123.4.665 · Cited by 858 · see citing works

A longitudinal study of abnormalities on MRI and disability from multiple sclerosis

Brex, P. A., Ciccarelli, O., O'Riordan, J. I., Sailer, M., Thompson, A. J., & Miller, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011341 · Cited by 861 · see citing works

Cortical lesions in multiple sclerosis

Kidd, D., Barkhof, F., McConnell, R., Algra, P. R., Allen, I. V., & Revesz, T. (1999) · Brain · doi:10.1093/brain/122.1.17 · Cited by 766 · see citing works

Diagnosis of multiple sclerosis: progress and challenges

Brownlee, W. J., Hardy, T. A., Fazekas, F., & Miller, D. H. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30959-x · Cited by 701 · see citing works

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005) · Neurology · doi:10.1212/01.wnl.0000176753.45410.8b · Cited by 679 · see citing works

The epidemiology of multiple sclerosis in Europe

Pugliatti, M., Rosati, G., Carton, H., Riise, T., Drulovic, J., Vécsei, L., & Milanov, I. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01342.x · Cited by 654 · see citing works

Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases

Evers, A. W. M., Kraaimaat, F. W., van Lankveld, W., Jongen, P. J. H., Jacobs, J. W. G., & Bijlsma, J. W. J. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.6.1026 · Cited by 657 · see citing works

Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis

Werring, D. J., Clark, C. A., Barker, G. J., Thompson, A. J., & Miller, D. H. (1999) · Neurology · doi:10.1212/wnl.52.8.1626 · Cited by 621 · see citing works

BREAKDOWN OF THE BLOOD-BRAIN BARRIER PRECEDES SYMPTOMS AND OTHER MRI SIGNS OF NEW LESIONS IN MULTIPLE SCLEROSIS: PATHOGENETIC AND CLINICAL IMPLICATIONS

KERMODE, A. G., THOMPSON, A. J., TOFTS, P., MACMANUS, D. G., KENDALL, B. E., KINGSLEY, D. P. E., MOSELEY, I. F., RUDGE, P., & MCDONALD, W. I. (1990) · Brain · doi:10.1093/brain/113.5.1477 · Cited by 578 · see citing works

The measurement of fatigue: a new instrument

Schwartz, J. E., Jandorf, L., & Krupp, L. B. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90104-n · Cited by 562 · see citing works

Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change

Benedict, R. H. B., Wahlig, E., Bakshi, R., Fishman, I., Munschauer, F., Zivadinov, R., & Weinstock-Guttman, B. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.12.009 · Cited by 528 · see citing works

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

Svendsen, K. B., Jensen, T. S., & Bach, F. W. (2004) · BMJ · doi:10.1136/bmj.38149.566979.ae · Cited by 500 · see citing works

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis

Kappos, L., Moeri, D., Radue, E. W., Schoetzau, A., Schweikert, K., Barkhof, F., Miller, D., Guttmann, C. R., Weiner, H. L., Gasperini, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03053-0 · Cited by 499 · see citing works

Quality of life in patients with multiple sclerosis

Janardhan, V., & Bakshi, R. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00312-x · Cited by 489 · see citing works

Epidemiologic evidence for multiple sclerosis as an infection

Kurtzke, J. F. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.382 · Cited by 472 · see citing works

Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study

Mokry, L. E., Ross, S., Ahmad, O. S., Forgetta, V., Smith, G. D., Leong, A., Greenwood, C. M. T., Thanassoulis, G., & Richards, J. B. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001866 · Cited by 445 · see citing works

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis

Miller, D. H., Albert, P. S., Barkhof, F., Francis, G., Frank, J. A., Hodgkinson, S., Lublin, F. D., Paty, D. W., Reingold, S. C., & Simon, J. (1996) · Annals of Neurology · doi:10.1002/ana.410390104 · Cited by 444 · see citing works

Validation of the Hospital anxiety and depression scale for use with multiple sclerosis patients

Honarmand, K., & Feinstein, A. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509347150 · Cited by 436 · see citing works

Anxiety disorders and their clinical correlates in multiple sclerosis patients

Korostil, M., & Feinstein, A. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071161 · Cited by 424 · see citing works

Interferon beta-1b in secondary progressive MS: Results from a 3-year controlled study

The North American Study Group on Interferon beta-1b in Secondary Progressive MS (2004) · Neurology · doi:10.1212/01.wnl.0000146958.77317.3e · Cited by 423 · see citing works

Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis

Mohr, D. C., Hart, S. L., Julian, L., Cox, D., & Pelletier, D. (2004) · BMJ · doi:10.1136/bmj.38041.724421.55 · Cited by 401 · see citing works

Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis

Filippi, M., Rocca, M. A., Martino, G., Horsfield, M. A., & Comi, G. (1998) · Annals of Neurology · doi:10.1002/ana.410430616 · Cited by 395 · see citing works

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.

Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.6.942 · Cited by 334 · see citing works

Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study

Stankoff, B., Waubant, E., Confavreux, C., Edan, G., Debouverie, M., Rumbach, L., Moreau, T., Pelletier, J., Lubetzki, C., Clanet, M., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000158272.27070.6a · Cited by 318 · see citing works

A High-Density Screen for Linkage in Multiple Sclerosis

(2005) · The American Journal of Human Genetics · doi:10.1086/444547 · Cited by 297 · see citing works

Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners: <b>Quality of life and emotional well-being in MS</b>

Janssens, A. C. J. W., van Doorn, P. A., de Boer, J. B., van der Meché, F. G. A., Passchier, J., & Hintzen, R. Q. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00166.x · Cited by 294 · see citing works

Dysexecutive syndrome: diagnostic criteria and validation study

Godefroy, O., Azouvi, P., Robert, P., Roussel, M., LeGall, D., Meulemans, T., & Behalf of the Groupe de Réflexion sur l'Evaluation des Fonctions Exécutives Study Group (2010) · Annals of Neurology · doi:10.1002/ana.22117 · Cited by 293 · see citing works

The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics

Minden, S. L., Frankel, D., Hadden, L., Perloff, J., Srinath, K. P., & Hoaglin, D. C. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1262oa · Cited by 272 · see citing works

Psychological interventions for multiple sclerosis.

Thomas, P. W., Thomas, S., Hillier, C., Galvin, K., & Baker, R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004431.pub2 · Cited by 271 · see citing works

MRI criteria for MS in patients with clinically isolated syndromes

Montalban, X., Tintoré, M., Swanton, J., Barkhof, F., Fazekas, F., Filippi, M., Frederiksen, J., Kappos, L., Palace, J., Polman, C., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cec45c · Cited by 252 · see citing works

Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern

Kroencke, D. C., Lynch, S. G., & Denney, D. R. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600213 · Cited by 253 · see citing works

Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients

Benito‐León, J., Morales, J. M., & Rivera‐Navarro, J. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00450.x · Cited by 246 · see citing works

Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter

Law, M., Saindane, A. M., Ge, Y., Babb, J. S., Johnson, G., Mannon, L. J., Herbert, J., & Grossman, R. I. (2004) · Radiology · doi:10.1148/radiol.2313030996 · Cited by 242 · see citing works

Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography

Wallin, M. T., Page, W. F., & Kurtzke, J. F. (2004) · Annals of Neurology · doi:10.1002/ana.10788 · Cited by 224 · see citing works

<i>In vivo</i>two-photon microscopy reveals immediate microglial reaction to implantation of microelectrode through extension of processes

Kozai, T. D. Y., Vazquez, A. L., Weaver, C. L., Kim, S.-G., & Cui, X. T. (2012) · Journal of Neural Engineering · doi:10.1088/1741-2560/9/6/066001 · Cited by 215 · see citing works

Depression and quality of life in multiple sclerosis: Depression and QoL in MS

Fruewald, S., Loeffler-Stastka, H., Eher, R., Saletu, B., & Baumhacki, U. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.00022.x · Cited by 211 · see citing works

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes

Cantó, E., Tintoré, M., Villar, L. M., Costa, C., Nurtdinov, R., Álvarez-Cermeño, J. C., Arrambide, G., Reverter, F., Deisenhammer, F., Hegen, H., et al. (2015) · Brain · doi:10.1093/brain/awv017 · Cited by 193 · see citing works

Telephone-administered cognitive–behavioral therapy for the treatment of depressive symptoms in multiple sclerosis.

Mohr, D. C., Likosky, W., Bertagnolli, A., Goodkin, D. E., Van Der Wende, J., Dwyer, P., & Dick, L. P. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.2.356 · Cited by 240 · see citing works

Oromucosal Δ9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial

ROG, D., NURMIKKO, T., & YOUNG, C. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.013 · Cited by 187 · see citing works

Differentiation of Multiple Sclerosis from Other Inflammatory Disorders and Cerebrovascular Disease: Value of Spinal MR Imaging

Bot, J. C. J., Barkhof, F., à Nijeholt, G. L., van Schaardenburg, D., Voskuyl, A. E., Ader, H. J., Pijnenburg, J. A. L., Polman, C. H., Uitdehaag, B. M. J., Vermeulen, E. G. J., et al. (2002) · Radiology · doi:10.1148/radiol.2231010707 · Cited by 168 · see citing works

The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis

Marrie, R. A., Zhang, L., Lix, L. M., Graff, L. A., Walker, J. R., Fisk, J. D., Patten, S. B., Hitchon, C. A., Bolton, J. M., Sareen, J., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.12.007 · Cited by 169 · see citing works

Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis

Fainardi, E., Castellazzi, M., Bellini, T., Manfrinato, M. C., Baldi, E., Casetta, I., Paolino, E., Granieri, E., & Dallocchio, F. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1274oa · Cited by 145 · see citing works

Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis.

Brown, R. F., Valpiani, E. M., Tennant, C. C., Dunn, S. M., Sharrock, M., Hodgkinson, S., & Pollard, J. D. (2009) · Psychology and Psychotherapy: Theory, Research and Practice · doi:10.1348/147608308x345614 · Cited by 150 · see citing works

ABNORMALITIES IN CENTRAL MOTOR PATHWAY CONDUCTION IN MULTIPLE SCLEROSIS

Cowan, J. M. A., Dick, J. P. R., Day, B. L., Rothwell, J. C., Thompson, P. D., & Marsden, C. D. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92683-7 · Cited by 151 · see citing works

Callosal Contributions to Simultaneous Bimanual Finger Movements

Bonzano, L., Tacchino, A., Roccatagliata, L., Abbruzzese, G., Mancardi, G. L., & Bove, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4076-07.2008 · Cited by 136 · see citing works

Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-lb: Relationship to adherence to treatment

Mohr, D. C., Goodkin, D. E., Likosk, W., Gatto, N., Neilley, L. K., Griffin, C., & Stiebling, B. (1996) · Multiple Sclerosis Journal · doi:10.1177/135245859600200502 · Cited by 131 · see citing works

Coping and Quality of Life in One Hundred and Thirty Five Subjects with Multiple Sclerosis

Montel, S. R., & Bungener, C. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071170 · Cited by 124 · see citing works

Hypothalamic lesions in multiple sclerosis

Huitinga, I., De Groot, C. J. A., Van der Valk, P., Kamphorst, W., Tilders, F. J. H., & Swaab, D. F. (2001) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1093/jnen/60.12.1208 · Cited by 120 · see citing works

Measuring Free-Living Physical Activity in Adults With and Without Neurologic Dysfunction With a Triaxial Accelerometer

Hale, L. A., Pal, J., & Becker, I. (2008) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2008.02.027 · Cited by 118 · see citing works

Information provision for people with multiple sclerosis

Köpke, S., Solari, A., Khan, F., Heesen, C., & Giordano, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008757.pub2 · Cited by 118 · see citing works

Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients

Bakshi, R., Dmochowski, J., Shaikh, Z. A., & Jacobs, L. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00477-4 · Cited by 107 · see citing works

Prediction of anxiety and distress following diagnosis of multiple sclerosis: a two-year longitudinal study

Janssens, A. C., Buljevac, D., van Doorn, P. A., van der Meché, F. G., Polman, C. H., Passchier, J., & Hintzen, R. Q. (2006) · Multiple Sclerosis Journal · doi:10.1177/1352458506070935 · Cited by 107 · see citing works

Identification of a Novel Risk Locus for Multiple Sclerosis at 13q31.3 by a Pooled Genome-Wide Scan of 500,000 Single Nucleotide Polymorphisms

Comabella, M., Craig, D. W., Camiña-Tato, M., Morcillo, C., Lopez, C., Navarro, A., Rio, J., BiomarkerMS Study Group, Montalban, X., & Martin, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003490 · Cited by 105 · see citing works

The Use of Standardized Incidence and Prevalence Rates in Epidemiological Studies on Multiple Sclerosis

Zivadinov, R., Iona, L., Monti-Bragadin, L., Bosco, A., Jurjevic, A., Taus, C., Cazzato, G., & Zorzon, M. (2003) · Neuroepidemiology · doi:10.1159/000067107 · Cited by 102 · see citing works

Personality dimensions in the chronic fatigue syndrome: a comparison with multiple sclerosis and depression

Johnson, S. K., DeLuca, J., & Natelson, B. H. (1996) · Journal of Psychiatric Research · doi:10.1016/0022-3956(95)00040-2 · Cited by 102 · see citing works

Illness perception and health-related quality of life in multiple sclerosis.

Spain, L. A., Tubridy, N., Kilpatrick, T. J., Adams, S. J., & Holmes, A. C. N. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00895.x · Cited by 97 · see citing works

Multiple sclerosis relapses and depression

Moore, P., Hirst, C., Harding, K. E., Clarkson, H., Pickersgill, T. P., & Robertson, N. P. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.08.004 · Cited by 80 · see citing works

A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a

Zivadinov, R., Zorzon, M., Tommasi, M. A., Nasuelli, D., Bernardi, M., Monti-Bragadin, L., & Cazzato, G. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00225-9 · Cited by 81 · see citing works

Interferon γ- and interleukin-4-secreting cells in multiple sclerosis

Lu, C.-Z., Jensen, M. A., & Arnason, B. G. W. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90241-p · Cited by 77 · see citing works

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options

Disanto, G., Benkert, P., Lorscheider, J., Mueller, S., Vehoff, J., Zecca, C., Ramseier, S., Achtnichts, L., Findling, O., Nedeltchev, K., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152347 · Cited by 76 · see citing works

Immunomodulatory therapies delay disease progression in multiple sclerosis

Bergamaschi, R., Quaglini, S., Tavazzi, E., Amato, M. P., Paolicelli, D., Zipoli, V., Romani, A., Tortorella, C., Portaccio, E., D’Onghia, M., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458512445941 · Cited by 71 · see citing works

Fatigue at time of CIS is an independent predictor of a subsequent diagnosis of multiple sclerosis

Runia, T. F., Jafari, N., Siepman, D. A. M., & Hintzen, R. Q. (2015) · Journal of Neurology, Neurosurgery &amp; Psychiatry · doi:10.1136/jnnp-2014-308374 · Cited by 70 · see citing works

Pain and Quality of Life in the Early Stages After Multiple Sclerosis Diagnosis: A 2-year Longitudinal Study

Brochet, B., Deloire, M. S. A., Ouallet, J.-C., Salort, E., Bonnet, M., Jové, J., & Petry, K. G. (2009) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181891347 · Cited by 69 · see citing works

Personality as a Predictor of Coping Efforts in Patients with Multiple Sclerosis

Rätsep, T., Kallasmaa, T., Pulver, A., & Gross-Paju, K. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600607 · Cited by 69 · see citing works

Iron chelation and multiple sclerosis

Weigel, K. J., Lynch, S. G., & LeVine, S. M. (2014) · ASN NEURO · doi:10.1042/an20130037 · Cited by 63 · see citing works

The Effect of Functional Limitations and Fatigue on the Quality of Life in People with Multiple Sclerosis

Nogueira, L. A. C., Nóbrega, F. R., Lopes, K. N., Thuler, L. C. S., & Alvarenga, R. M. P. (2009) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2009000500006 · Cited by 63 · see citing works

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis

Mattsson, N., Axelsson, M., Haghighi, S., Malmeström, C., Wu, G., Anckarsäter, R., Sankaranarayanan, S., Andreasson, U., Fredrikson, S., Gundersen, A., et al. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458508100031 · Cited by 61 · see citing works

Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis

Lode, K., Bru, E., Klevan, G., Myhr, K., Nyland, H., & Larsen, J. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509102313 · Cited by 60 · see citing works

Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research

Snow, N. J., Wadden, K. P., Chaves, A. R., & Ploughman, M. (2019) · Neural Plasticity · doi:10.1155/2019/6430596 · Cited by 56 · see citing works

A randomized group intervention trial to enhance mood and self-efficacy in people with multiple sclerosis

Rigby, S. A., Thornton, E. W., & Young, C. A. (2008) · British Journal of Health Psychology · doi:10.1348/135910707x241505 · Cited by 54 · see citing works

Hepatitis B vaccination and the putative risk of central demyelinating diseases – a systematic review and meta-analysis.

Mouchet, J., Salvo, F., Raschi, E., Poluzzi, E., Antonazzo, I. C., De Ponti, F., & Bégaud, B. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.036 · Cited by 49 · see citing works

Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis

Rubio, J. P., Tubridy, N., Bahlo, M., Stankovich, J., Burfoot, R., Butzkueven, H., Chapman, C., Johnson, L., Marriott, M., Mraz, G., et al. (2004) · Human Genetics · doi:10.1007/s00439-004-1095-9 · Cited by 43 · see citing works

Interferon-β_1bin multiple sclerosis

Buttmann, M., & Rieckmann, P. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.3.227 · Cited by 43 · see citing works

Correlates of Coping Style in Patients with Multiple Sclerosis

Beatty, W. W., Hames, K. A., Blanco, C. R., Williamson, S. J., Wilbanks, S. L., & Olson, K. A. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400507 · Cited by 44 · see citing works

Gastric motility dysfunction in patients with multiple sclerosis assessed by gastric emptying scintigraphy

El-Maghraby, T. A., Shalby, N. M., Al-Tawdy, M. H., & Salem, S. S. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/103615 · Cited by 35 · see citing works

Intrathecal chitotriosidase and the outcome of multiple sclerosis

Sotgiu, S., Barone, R., Arru, G., Fois, M. L., Pugliatti, M., Sanna, A., Rosati, G., & Musumeci, S. (2006) · Multiple Sclerosis Journal · doi:10.1177/1352458506070614 · Cited by 33 · see citing works

Working memory deficits in multiple sclerosis: A controlled study with auditory P600 correlates

Sfagos, C. (2003) · Journal of Neurology, Neurosurgery &amp; Psychiatry · doi:10.1136/jnnp.74.9.1231 · Cited by 28 · see citing works

Paediatric multiple sclerosis: examining utility of the McDonald 2010 criteria

Sedani, S., Lim, M., Hemingway, C., Wassmer, E., & Absoud, M. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458511426815 · Cited by 28 · see citing works

Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis

Alcina, A., Fernández, Ó., Gonzalez, J. R., Catalá-Rabasa, A., Fedetz, M., Ndagire, D., Leyva, L., Guerrero, M., Arnal, C., Delgado, C., et al. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.240 · Cited by 27 · see citing works

The initial course of daily functioning in multiple sclerosis: a three-year follow-up study

de Groot, V, Beckerman, H., Lankhorst, G. J., Polman, C. H., & Bouter, L. M. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1238oa · Cited by 23 · see citing works

Assessment of the hypothalamic-pituitary-adrenal axis function after corticosteroid therapy for MS relapses

Miró, J., Amado, J. A., Pesquera, C., López-Cordovilla, J. J., & Berciano, J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1990.tb01013.x · Cited by 13 · see citing works

Changes in LORETA and conventional patterns of P600 after steroid treatment in multiple sclerosis patients

Papageorgiou, C. C., Sfagos, C., Kosma, K. K., Kontoangelos, K. A., Triantafyllou, N., Vassilopoulos, D., Rabavilas, A. D., & Soldatos, C. R. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.07.005 · Cited by 8 · see citing works

Pharmacologic treatment of depression in multiple sclerosis.

Koch, M. W., Glazenborg, A., Uyttenboogaart, M., Mostert, J. P., & De Keyser, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007295 · Cited by 8 · see citing works

The Prevalence of Neuropathic Pain in Multiple Sclerosis—A Systematic Review and Meta‐Analysis Using the <scp>NeuPSIG</scp> Algorithm

Jungersen, R. C., Baccaro, V. K., Hvid, L. G., Dalgas, U., & Hoegh, M. (2026) · European Journal of Pain · doi:10.1002/ejp.70375 · Cited by 1 · see citing works